Ovarian stimulation cycles with a fixed vs. a flexible gonadotropin releasing hormone (GnRH) antagonist protocol compared to a long GnRH analog protocol in an oocyte donation program.

被引:0
|
作者
Lopez, J. C. [1 ]
Cano, F. [1 ]
Jaller, A. [1 ]
Giraldo, J. L. [1 ]
Posada, M. N. [1 ]
Raigosa, G. C. [1 ]
机构
[1] INSER, Inst Antioquento Reprod, Medellin, Antioquia, Colombia
关键词
D O I
10.1016/j.fertnstert.2007.07.984
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:S292 / S292
页数:1
相关论文
共 50 条
  • [11] New protocol of ovulation induction with GnRH antagonist compared with GnRH analogue long protocol in IVFET/ICSI cycles
    Saini, P.
    Saini, A.
    HUMAN REPRODUCTION, 2010, 25 : I317 - I317
  • [12] Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
    Ibrahim, Zakia
    Youssef, Heba
    Elbialy, Magda
    Farrag, Mohamed
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2011, 16 (04) : 272 - 277
  • [13] Predictive factors of ovarian response in gonadotropin releasing hormone (GNRH) antagonist cycles.
    Ganidou, M.
    Kolibianakis, E. M.
    Venetis, C. A.
    Papanikolaou, E. G.
    Bontis, J.
    Tarlatzis, B. C.
    FERTILITY AND STERILITY, 2007, 88 : S170 - S170
  • [14] Use of gonadotropin releasing hormone (GnRH) antagonist vs agonist in repeat stimulation cycles of poor responders.
    Jindal, SK
    Gatzen, C
    Barad, D
    FERTILITY AND STERILITY, 2002, 78 (03) : S151 - S151
  • [15] Microdose gonadotrophin releasing hormone agonist (GnRH-A) flare protocol compared with standard long protocol GnRH-A for ovarian stimulation in patients undergoing in vitro fertilization.
    Kelly, SM
    Pirwany, IR
    Phillips, SJ
    Tan, SL
    FERTILITY AND STERILITY, 2002, 78 (03) : S234 - S234
  • [16] Choice of medication for oocyte maturation for in vitro fertilization (IVF) gonadotropin releasing hormone (GnRH) antagonist cycles:: Human chorionic gonadotropin (hCG) vs. leuprolide acetate
    Johnston-MacAnanny, E. B.
    DiLuigi, A. J.
    Benadiva, C. A.
    Maier, D. B.
    Nulsen, J. C.
    Engmann, L. L.
    FERTILITY AND STERILITY, 2007, 88 : S142 - S142
  • [17] PROGNOSTIC MODELS FOR HIGH AND LOW OVARIAN RESPONSE IN CONTROLLED OVARIAN STIMULATION (COS) USING A GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONIST PROTOCOL.
    Broekmans, F.
    Verweij, P.
    Eijkemans, M.
    Mannaerts, B.
    Witjes, H.
    FERTILITY AND STERILITY, 2012, 98 (03) : S275 - S275
  • [18] Single dose nasal spray of gonadotropin releasing hormone (GnRH) agonist effectively matures oocytes for in vitro fertilization in an ovarian stimulation protocol using clomiphene citrate, gonadotropin, and GnRH antagonist.
    Goto, T
    Oka, C
    Tomiyama, T
    Mukaida, T
    Takahashi, K
    FERTILITY AND STERILITY, 2003, 80 : S6 - S6
  • [19] Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
    Dietrich, Jens E.
    Freis, Alexander
    Beedgen, Franziska
    von Horn, Kyra
    Holschbach, Verena
    Liebscher, Julia
    Strowitzki, Thomas
    Germeyer, Ariane
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [20] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Ginevra Mills
    Michael H. Dahan
    Archives of Gynecology and Obstetrics, 2022, 306 : 1731 - 1737